Compare VATE & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VATE | CSBR |
|---|---|---|
| Founded | 1994 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 65.4M |
| IPO Year | 1996 | 2015 |
| Metric | VATE | CSBR |
|---|---|---|
| Price | $5.37 | $4.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 54.4K | 8.2K |
| Earning Date | 11-16-2026 | 12-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,246,000,000.00 | $2,900,000.00 |
| Revenue This Year | N/A | $9.83 |
| Revenue Next Year | N/A | $8.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 12.55 | N/A |
| 52 Week Low | $3.75 | $4.59 |
| 52 Week High | $21.30 | $8.31 |
| Indicator | VATE | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 29.69 | 48.67 |
| Support Level | $5.35 | $4.71 |
| Resistance Level | $5.56 | $5.17 |
| Average True Range (ATR) | 0.36 | 0.20 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 4.02 | 42.31 |
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.